| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) | 
|---|
| 03/13/2012 | CA2502358C Methods for purifying radiolabelled compounds | 
| 03/13/2012 | CA2419607C Peptidomimetic protease inhibitors | 
| 03/13/2012 | CA2365898C Ibd-associated microbial antigens and methods of using same | 
| 03/13/2012 | CA2330492C Novel octahydro-6,10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds | 
| 03/08/2012 | WO2012031250A2 Compositions for labeling nerves and methods of use | 
| 03/08/2012 | WO2012030217A2 Culture medium for eukaryotic cells | 
| 03/08/2012 | WO2011123179A3 Alkylated sp-c peptoid compounds and related surfactant compositions | 
| 03/08/2012 | US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell | 
| 03/08/2012 | US20120058957 Compositions and methods for counteracting effects of reactive oxygen species and free radicals | 
| 03/08/2012 | US20120058953 Compositions and methods for enhancing apoptosis | 
| 03/08/2012 | US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them | 
| 03/08/2012 | US20120058937 Prodrugs of Neuraminidase Inhibitors | 
| 03/08/2012 | US20120058932 Active ingredient-peptide construct for extracellular concentration | 
| 03/08/2012 | US20120058905 DNA Sequences Encoding Caryophyllaceae and Caryophyllaceae-Like Cyclopeptide Precursors and Methods of Use | 
| 03/08/2012 | US20120055781 Microwave-assisted peptide synthesis | 
| 03/08/2012 | CA2807895A1 Culture medium for eukaryotic cells | 
| 03/07/2012 | CN101735306B Anti-inflammatory peptide with membrane penetration effect | 
| 03/06/2012 | US8129561 Processes for intermediates for macrocyclic compounds | 
| 03/06/2012 | US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer | 
| 03/06/2012 | US8129346 Compounds for enzyme inhibition | 
| 03/06/2012 | US8129342 High purity lipopeptides | 
| 03/06/2012 | US8129332 Reagents and methods for smooth muscle therapies | 
| 03/06/2012 | CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens | 
| 03/01/2012 | US20120052094 Agonists of Neurotrophin Receptors and Their Use as Medicaments | 
| 03/01/2012 | DE102010036261A1 New peptide having a length of two to five monomers, where the monomers are an alpha hydroxy-4(1H)-pyridinone compounds, useful to treat metal (preferably iron, copper or aluminum) storage disorders, preferably siderosis | 
| 02/29/2012 | EP2421886A2 Peptide compositions | 
| 02/29/2012 | EP2421885A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same | 
| 02/29/2012 | EP2421884A1 Peptide hydrolysate proteasome activators and compositions containing same | 
| 02/29/2012 | EP2421883A1 Trapping compounds and method for identifying reactive metabolites | 
| 02/29/2012 | CN102365294A Dipeptide mimetics of ngf and bdnf neurotrophins | 
| 02/29/2012 | CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof | 
| 02/29/2012 | CN101267830B Growth hormone secretagogues | 
| 02/28/2012 | US8124725 PDGF-Rβ binders | 
| 02/28/2012 | US8124584 Macrocyclic hepatitis C serine protease inhibitors | 
| 02/23/2012 | WO2010146172A3 New synthetic route for the preparation of alpha-amino boronic esters | 
| 02/23/2012 | US20120046591 Treatment devices and methods with extending elements | 
| 02/23/2012 | US20120046586 Skin treatment devices and methods with pre-stressed configurations | 
| 02/23/2012 | US20120046445 Glutathione-based delivery system | 
| 02/23/2012 | US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery | 
| 02/23/2012 | US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof | 
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display | 
| 02/22/2012 | EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate | 
| 02/22/2012 | EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function | 
| 02/22/2012 | EP2419437A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions | 
| 02/22/2012 | EP2086995B1 Hepatitis c virus inhibitors | 
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme | 
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally | 
| 02/16/2012 | WO2012020364A1 Di peptide derivative for the treatment of cancer | 
| 02/16/2012 | WO2012019299A1 Hepatitis c inhibitor compounds | 
| 02/16/2012 | WO2005110456A8 T-cell death-inducing epitopes | 
| 02/16/2012 | US20120040912 Proteasome-activating anti-aging peptides and compositions containing same | 
| 02/15/2012 | EP2417151A1 Cyclic peptides with an anti-parasitic activity | 
| 02/15/2012 | EP2417108A1 Organic compounds and their uses | 
| 02/14/2012 | US8114830 Polypeptoid pulmonary surfactants | 
| 02/14/2012 | US8114439 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions | 
| 02/14/2012 | US8114431 Biomolecular coating for implants | 
| 02/09/2012 | WO2012019160A1 Dipeptides to enhance yield and viability from cell cultures | 
| 02/09/2012 | US20120035345 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | 
| 02/09/2012 | US20120035108 Spray base material including low-molecular gelator | 
| 02/09/2012 | US20120034593 Cyclic peptides with an anti-parasitic activity | 
| 02/09/2012 | US20120034364 Use of peptides for imparting kokumi | 
| 02/09/2012 | US20120034187 Hepatitis C Inhibitor Compounds | 
| 02/09/2012 | US20120031423 Bleaching composition | 
| 02/09/2012 | CA2807511A1 Processes for preparing tubulysins | 
| 02/08/2012 | EP2414382A2 Novel proteasome-activating lightening peptides and compositions containing same | 
| 02/08/2012 | EP2414381A2 Proteasome-activating anti-aging peptides and compositions containing same | 
| 02/08/2012 | EP2413891A2 Novel proteasome-activating anti-aging peptides and compositions containing same | 
| 02/08/2012 | EP1682074B1 Compositions and methods for healthy pregnancy | 
| 02/08/2012 | CN101060854B 具有抗糖尿病作用的蛋白质水解物 Protein hydrolysates have anti-diabetic action | 
| 02/07/2012 | US8110658 Peptide fragments for inducing synthesis of extracellular matrix proteins | 
| 02/07/2012 | US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof | 
| 02/07/2012 | US8110402 Metal abstraction peptide (MAP) tag and associated methods | 
| 02/07/2012 | CA2524222C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination | 
| 02/02/2012 | WO2012013136A1 Polypeptidic tyrosinase inhibitor | 
| 02/02/2012 | WO2012012843A1 Modulators of protease activated receptors | 
| 02/02/2012 | US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof | 
| 02/02/2012 | US20120028888 Apj receptor compounds | 
| 02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides | 
| 02/02/2012 | US20120027703 Novel proteasome-activating anti-aging peptides and compositions containing same | 
| 02/02/2012 | US20120027677 Prion-specific peptoid reagents | 
| 02/01/2012 | EP2412720A2 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | 
| 02/01/2012 | EP2088152B1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent | 
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor | 
| 02/01/2012 | CN102337318A Gingko antioxidant active peptide and preparation method thereof | 
| 02/01/2012 | CN102336807A Industrialization preparation method for RDG peptide | 
| 02/01/2012 | CN101602792B 一种新型抗菌脂肽及其制备和应用 A novel antibacterial lipopeptide its preparation and application | 
| 02/01/2012 | CN101153053B 骨生肽、其制备方法和其药物组合物与用途 Bone peptides, their preparation and pharmaceutical compositions and uses thereof | 
| 01/31/2012 | US8106158 Compositions and methods for fusion protein separation | 
| 01/31/2012 | US8106020 Calcium receptor activator | 
| 01/31/2012 | US8106006 Modified defensins and their use | 
| 01/31/2012 | CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants | 
| 01/26/2012 | WO2012010287A1 Tubulysin analogues | 
| 01/26/2012 | US20120022371 Compositions and methods for detecting and treating tumors containing acidic areas | 
| 01/26/2012 | US20120022004 Treatment of t-cell mediated diseases | 
| 01/26/2012 | US20120021970 Methods for preventing or treating mitochondrial permeability transition | 
| 01/26/2012 | US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS | 
| 01/26/2012 | US20120021454 Rapid fret-based diagnosis of bacterial pathogens | 
| 01/26/2012 | US20120021430 Functional lipid constructs | 
| 01/26/2012 | US20120021029 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions | 
| 01/26/2012 | US20120020964 Antibodies for Norovirus |